Le Lézard
Classified in: Science and technology
Subjects: PDT, POL

Wuga's Web-App is Depolarizing Debate Around Politics


HOUSTON, Nov. 2, 2020 /PRNewswire/ -- The Wuga Web-App released their cure to heated discussions around politics. Wuga is a test designed to tell you where you stand on Economic, Diplomatic, Civil, and Social issues. It was inspired by the Political Coordinates test, but Wuga says they have bigger plans for their application. The founders believe that showing people their own values will help them make better decisions as voters, something more important now than ever. What's more is that for the first time, test-takers will see how they relate to other political biases in their country and region. Before heading to the polls, every voter should try the app to know exactly where their political bias falls.

"People don't know where they stand on the political scale. That's what surprised us the most." The founders were inspired to bring deeper meaning to the political coordinates test after finding out that their biases were closer than they thought. "We want to make it easier for young voters to relate to one another on the values that they are fighting for." Don't go to vote without knowing where you stand, head over to wuga.app and find out your political score and how you relate to others.

Wuga Web-App Features

Find Your Political Score For Free

Learning about your political bias is now easier than ever with the Wuga Web-App. Find out where you stand on the four-core issues: Economic, Diplomatic, Civil, and Societal.

Wuga.app is the place to start your test and get your political score.

Additional Information

Journalists interested in receiving one should contact John Walston, CEO - [email protected].

About Wuga

Young voters are taking the test that clears up confusion at the polls. Wuga shows you your political score by answering a series of questions based on their core values.

Press Contact

Wuga LLC, La Porte, TX, 77571.

Mobile: 713-367-8814 Email: [email protected]    

Twitter: https://twitter.com/Wuga_app

Website: wuga.app

SOURCE Wuga LLC


These press releases may also interest you

at 20:14
Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC)
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE joins Mastercard's Priceless Planet Coalition
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
E&R Engineering Corp. Unveils Cutting-Edge Solutions at Semicon SEA 2024 in Kuala Lumpur
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines' ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

More news about Science and technology...


News published on and distributed by: